228. Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk

BACKGROUND: Fluoroquinolones were commonly prescribed for hospitalized patients with diabetic foot infection (DFI) at our institution, included in 69% of empiric antibiotic regimens from 2011–2014. On December 20, 2018, the U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication r...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Catherine, Mercuro, Nicholas J, Chapin, Ryan, Gold, Howard, McCoy, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776833/
http://dx.doi.org/10.1093/ofid/ofaa439.272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776833/
http://dx.doi.org/10.1093/ofid/ofaa439.272

Ejemplares similares